Body mass index at time of HIV diagnosis: A strong and independent predictor of survival

Marianne A.B. Van Der Sande, Maarten F. Shim Van Der Loeff, Akum A. Aveika, Saihou Sabally, Toyin Togun, Ramu Sarge-Njie, Abraham S. Alabi, Assan Jaye, Tumani Corrah, Hilton C. Whittle

Research output: Contribution to journalArticle

Abstract

Background: Identification of basic prognostic indicators of HIV infection is essential before widespread antiretroviral therapy can be implemented in low-technology settings. This study assessed how well body mass index (BMI:kg/m2) predicts survival. Methods: BMI within 3 months of HIV diagnosis was obtained from 1657 patients aged ≥15 years, recruited in a seroprevalent clinical cohort in The Gambia since 1992 and followed up at least once. Baseline CD4+ counts and clinical assessment at time of diagnosis were done. Results: The mortality hazard ratio (HR) of those with a baseline BMI <18 compared with those with a baseline BMI ≥18 was 3.4 (95% CI, 3.0-3.9). The median survival time of those presenting with a BMI <16 was 0.8 years, in contrast to a median survival of 8.9 years for those with a baseline BMI ≥22. Baseline BMI <18 remained a highly significant independent predictor of mortality after adjustment for age, sex, co-trimoxazole prophylaxis, tuberculosis, reported wasting at diagnosis, and baseline CD4 + cell count (adjusted HR = 2.5, 95% CI 2.0-3.0). Sensitivity and specificity of baseline BMI <18 was comparable to that of a CD4+ count <200 in predicting mortality within 6 months of diagnosis. Discussion: BMI at diagnosis is a strong, independent predictor of survival in HIV-infected patients in West Africa. In the absence of sophisticated clinical and laboratory support, BMI may also prove a useful guide for deciding when to initiate antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)1288-1294
Number of pages7
JournalJournal of acquired immune deficiency syndromes
Volume37
Issue number2
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Keywords

  • Africa
  • Body mass index
  • CD4 count
  • Cohort
  • HIV-1
  • HIV-2
  • Survival

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Body mass index at time of HIV diagnosis: A strong and independent predictor of survival'. Together they form a unique fingerprint.

  • Cite this

    Van Der Sande, M. A. B., Shim Van Der Loeff, M. F., Aveika, A. A., Sabally, S., Togun, T., Sarge-Njie, R., Alabi, A. S., Jaye, A., Corrah, T., & Whittle, H. C. (2004). Body mass index at time of HIV diagnosis: A strong and independent predictor of survival. Journal of acquired immune deficiency syndromes, 37(2), 1288-1294. https://doi.org/10.1097/01.qai.0000122708.59121.03